Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Due Diligence
Comparison
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Companies

Displaying 1..9 of 9 - per page
Order by
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes. More
Active Biotech AB is a Swedish biotech company focusing on the research and development of pharmaceuticals, primarily for the treatment of autoimmune / inflammatory diseases and cancer. More
QMUL aims to create social and economic benefits for society by developing a culture of innovation and enterprise that will facilitate the commercial exploitation of academic research and technology. More
Farmacija is a pharmaceutical company focusing on the discovery and development of innovative peptide-based drugs, primarily for the treatment of auto-immune and inflammatory diseases. More
Developer of innovative cancer and inflammatory disease treatments, which are small molecule, orally administered, highly specific towards their target and have no noticeable toxicity. More
A biopharmaceutical company, pioneering a unique, highly integrated chemical genetics platform for drug discovery and development - focused on oncology & autoimmune/inflammatory diseases More
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) designs, optimizes and develops novel drugs that block key enzymes essential for viral, cardiovascular and oncologic disease processes. More
CytoGenix, Inc. is a biopharmaceutical company that develops and markets innovative compounds and services based on its proprietary gene regulating technology. More
Displaying 1..9 of 9 - per page
Order by

Your selection

Industry sector
Drug discovery del
Therapeutic target
Immune related disorders del
Autoimmune disease (non-specific) del

Browse By

Partnering consultation free of charge
Pharma Business Strategies for Biomarkers
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us